NUCLEAR ONCOLOGY

Nuclear Oncology combines molecular imaging with radiotheranostics (sometimes referred to as Peptide Receptor Radionuclide Therapy (PRRT)) which are injectable radiopharmaceuticals with antitumor effects. Spect CT imaging is utilized in staging and follow-up to visualize the effectiveness of the treatment and progress in reducing or eliminating cancerous tumor cells.

LUTATHERA

LUTATHERA is a prescription treatment for adults with specific types of cancer. The therapy is delivered via intravenous infusion and is designed to attach to targeted cancer cells. Once delivered, LUTATHERA introduces radiation to the tumor damaging the targeted cells. Until recently, local patients were required to travel to a large medical center outside the region to receive this therapy.  LUTATHERA is now available to patients in the Inland Northwest through the Nuclear Medicine and Interventional Radiology Departments at Inland Imaging.